Home Top News Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold... Top News Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold gains by 2030, Goldman Sachs says By - November 5, 2023 0 14 Facebook Twitter Pinterest WhatsApp [#item_full_content] RELATED ARTICLESMORE FROM AUTHOR Macy’s mulling $5.8 billion buyout offer: source Cigna Calls Off Humana Pursuit, Plans Big Stock Buyback Stocks Poised for Muted Open LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. AT&T Fires Back On Lead-Sheathed Cabling Issue, Telecom Stocks Climb If You Retire at 45, $10 Million Will Last This Long J.P. Morgan & Fidelity Reports: Realistic Retirement Rate of Return By... Cerberus, Highgate Miss Payments on $415 Million Hotel Mortgage Australia Farmers Are Giving Sheep Away for Free After 75% Price...
